# X chromosome-encoded microRNAs in immune regulation: sex differences and clinical implications

**Authors:** Valeria Lodde, Valentina Margarita, Myriam Gorospe, Ilaria Campesi

PMC · DOI: 10.3389/fgwh.2026.1758961 · Frontiers in Global Women's Health · 2026-02-19

## TL;DR

This paper explores how X chromosome-encoded microRNAs influence immune responses differently in males and females, potentially explaining sex differences in autoimmune diseases and immune function.

## Contribution

The paper highlights the role of X chromosome-encoded miRNAs in immune regulation and their potential as sex-aware biomarkers and therapeutic targets.

## Key findings

- X chromosome-encoded miRNAs are key regulators of immune homeostasis and are enriched in immune-related pathways.
- Some X-resident miRNAs escape inactivation, leading to female-biased expression that may enhance immune reactivity and autoimmunity.
- These miRNAs are proposed as potential biomarkers and therapeutic targets for sex-aware precision medicine.

## Abstract

Sex-based differences in immune function influence susceptibility to infections and predisposition to autoimmunity, with women showing both stronger immune responses and a higher burden of autoimmune and chronic inflammatory diseases. While sex hormones contribute to these differences, accumulating evidence highlights a central role for the X chromosome, which is enriched in immune-related genes and subject to complex regulatory mechanisms such as X-chromosome inactivation, skewing, escape from inactivation, and imprinting. Within this context, X chromosome–encoded microRNAs (miRNAs) have emerged as key post-transcriptional regulators of immune homeostasis. The X chromosome harbors the highest density of miRNAs in the human genome, many of which target pathways involved in immune activation, tolerance, and tumorigenesis. Notably, some X-resident miRNAs escape X-chromosome inactivation, leading to female-biased expression that may enhance immune reactivity but also predispose to loss of tolerance and autoimmunity. In this minireview, we summarize current knowledge on X chromosome–encoded miRNAs in immune regulation, discuss how their sex-biased expression patterns may contribute to female predominance in autoimmune diseases, and explore their potential utility as biomarkers and therapeutic targets for sex-aware precision medicine in inflammatory, autoimmune disorders and vaccine responses.

## Full-text entities

- **Genes:** S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, MIR421 (microRNA 421) [NCBI Gene 693122] {aka MIRN421, hsa-mir-421}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, MIR19B1 (microRNA 19b-1) [NCBI Gene 406980] {aka C13orf25, MIR19B, MIRH1, MIRHG1, MIRN19B1, miR-19b-1}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, MIR548AM (microRNA 548am) [NCBI Gene 100616428], MIR548M (microRNA 548m) [NCBI Gene 100313772] {aka MIRN548M}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, MIR18B (microRNA 18b) [NCBI Gene 574033] {aka MIRN18B, hsa-mir-18b, mir-18b}, MIR542 (microRNA 542) [NCBI Gene 664617] {aka MIRN542, hsa-mir-542, mir-542}, FTX (FTX transcript, XIST regulator) [NCBI Gene 100302692] {aka LINC00182, MIR374AHG, NCRNA00182}, MIR20B (microRNA 20b) [NCBI Gene 574032] {aka MIRN20B, hsa-mir-20b, mir-20b}, MIR30E (microRNA 30e) [NCBI Gene 407034] {aka MIR30E*, MIRN30E, mir-30e}, DGCR8 (DGCR8 microprocessor complex subunit) [NCBI Gene 54487] {aka C22orf12, DGCRK6, Gy1, pasha}, MIR155 (microRNA 155) [NCBI Gene 406947] {aka MIRN155, miRNA155, mir-155}, PTPN2 (protein tyrosine phosphatase non-receptor type 2) [NCBI Gene 5771] {aka PTN2, PTPT, TC-PTP, TC45, TC48, TCELLPTP}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, MIR18A (microRNA 18a) [NCBI Gene 406953] {aka C13orf25, MIR18, MIRH1, MIRHG1, MIRN18, MIRN18A}, MIR19B2 (microRNA 19b-2) [NCBI Gene 406981] {aka MIRN19B2, miR-19b-2}, MIR221 (microRNA 221) [NCBI Gene 407006] {aka MIRN221, miRNA221, mir-221}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, MIR500A (microRNA 500a) [NCBI Gene 574502] {aka MIR500, MIRN500, hsa-mir-500, hsa-mir-500a, mir-500a}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, TLR7 (toll like receptor 7) [NCBI Gene 51284] {aka IMD74, SLEB17, TLR7-like}, MIR424 (microRNA 424) [NCBI Gene 494336] {aka MIR322, MIRN424, hsa-mir-424, miRNA424, mir-424}, STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, DROSHA (drosha ribonuclease III) [NCBI Gene 29102] {aka ETOHI2, HSA242976, RANSE3L, RN3, RNASE3L, RNASEN}, CEMIP (cell migration inducing hyaluronidase 1) [NCBI Gene 57214] {aka CCSP1, CEMIP1, HYBID, KIAA1199, TMEM2L}, MIR508 (microRNA 508) [NCBI Gene 574513] {aka MIRN508, hsa-mir-508}, MIR106A (microRNA 106a) [NCBI Gene 406899] {aka MIRN106A, mir-106, mir-106a}, CTPS2 (CTP synthase 2) [NCBI Gene 56474] {aka GATD5B}, CXCL10 (C-X-C motif chemokine ligand 10) [NCBI Gene 3627] {aka C7, IFI10, INP10, IP-10, SCYB10, crg-2}, MIR223 (microRNA 223) [NCBI Gene 407008] {aka MIRN223, miRNA223, mir-223}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, SPI1 (Spi-1 proto-oncogene) [NCBI Gene 6688] {aka AGM10, OF, PU.1, SFPI1, SPI-1, SPI-A}, MIR532 (microRNA 532) [NCBI Gene 693124] {aka MIRN532, hsa-mir-532, mir-532}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, MIR448 (microRNA 448) [NCBI Gene 554212] {aka MIRN448, hsa-mir-448, miRNA448}, MIR363 (microRNA 363) [NCBI Gene 574031] {aka MIR-363, MIRN363, hsa-mir-363}, MIR224 (microRNA 224) [NCBI Gene 407009] {aka MIRN224, miRNA224}, NFIA (nuclear factor I A) [NCBI Gene 4774] {aka BRMUTD, C1DELp32p31, CTF, DEL1P32P31, NF-I/A, NF1-A}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, COL12A1 (collagen type XII alpha 1 chain) [NCBI Gene 1303] {aka BA209D8.1, BTHLM2, COL12A1L, DJ234P15.1, EDSMYP, UCMD2}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, MIR20A (microRNA 20a) [NCBI Gene 406982] {aka C13orf25, MIR20, MIRH1, MIRHG1, MIRN20, MIRN20A}, MIR222 (microRNA 222) [NCBI Gene 407007] {aka MIRN222, miRNA222, mir-222}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, TLR8 (toll like receptor 8) [NCBI Gene 51311] {aka CD288, IMD98, TLR-8, hTLR8}, MIR203A (microRNA 203a) [NCBI Gene 406986] {aka MIR203, MIRN203, hsa-mir-203a, miR-203, miRNA203, mir-203a}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, AKT2 (AKT serine/threonine kinase 2) [NCBI Gene 208] {aka HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA}, MIR34B (microRNA 34b) [NCBI Gene 407041] {aka MIRN34B, miRNA34B, mir-34b}, MIR340 (microRNA 340) [NCBI Gene 442908] {aka MIRN340, hsa-mir-340, mir-340}, MIR505 (microRNA 505) [NCBI Gene 574508] {aka MIRN505, hsa-mir-505, mir-505}, MIR503 (microRNA 503) [NCBI Gene 574506] {aka MIRN503, hsa-mir-503, mir-503}
- **Diseases:** ADs (MESH:D001327), inflammatory bowel disease (MESH:D015212), renal damage (MESH:D007674), measles (MESH:D008457), autoimmune thyroiditis (MESH:D013967), T1D (MESH:D003922), carcinogenesis (MESH:D063646), immune-mediated diseases (MESH:C567355), T-cell leukemias (MESH:D015458), nephritis (MESH:D009393), diphtheria (MESH:D004165), psoriasis (MESH:D011565), MS (MESH:D009103), pertussis (MESH:D014917), infectious diseases (MESH:D003141), Graves' disease (MESH:D006111), renal cell carcinoma (MESH:D002292), SLE (MESH:D008180), autoimmune and chronic inflammatory diseases (MESH:D019693), fibrosis (MESH:D005355), RA (MESH:D001172), fibrotic diseases (MESH:D004194), inflammation (MESH:D007249), demyelinating disease (MESH:D003711), influenza (MESH:D007251), pneumococcal (MESH:D011008), deaths (MESH:D003643), COVID-19 (MESH:D000086382), Sjogren's syndrome (MESH:D012859), rabies (MESH:D011818), cancer (MESH:D009369), lupus nephritis (MESH:D008181), infections (MESH:D007239), hepatitis B (MESH:D006509), neuroinflammatory (MESH:D000090862)
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Ebola virus (no rank) [taxon 1570291], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960141/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960141/full.md

## References

101 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960141/full.md

---
Source: https://tomesphere.com/paper/PMC12960141